With a market share of 27.3% registered in September, the expectation is that by the end of the year, the participation of generics at retail is elevated to at least 30%, according to the Brazilian Association of generic drug Industries (PróGenéricos), based on data from IMS Health consulting. In the third quarter, manufacturers of generics sold 229.8 million units at retail, high of 10.1% compared to the previous year. The recipe, in turn, reached r $ 1.9 billion, 18.8% above the calculated amount a year earlier. (Economic Value)
Giro News - 22/10/2014
Related products
News Item translated automatically
Click HERE to see original